StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research report released on Wednesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Price Performance
Shares of NASDAQ TTNP opened at $6.13 on Wednesday. Titan Pharmaceuticals has a 12 month low of $4.24 and a 12 month high of $14.80. The business has a 50-day moving average of $5.92 and a 200-day moving average of $6.64.
Titan Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Titan Pharmaceuticals
- What is a Dividend King?
- Lumen: Among Top Performers Last Month, Still Has Warning Signs
- What is a Death Cross in Stocks?
- Baidu’s Strong Quarter Proves a Smart Pick for Michael Burry
- Investing in Commodities: What Are They? How to Invest in Them
- Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.